Finance

Lists
Why is BETR up 2,04%?
Dive Deeper
BETR:CNSX
BetterLife Pharma Inc
CAD 0,25
+2,04%
(+0,0050) 1D
14 Okt., 09:30:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BETR...
Open
CAD 0,25
High
CAD 0,25
Low
CAD 0,25
Mkt. cap
151,41 m
Avg. vol.
398,90 k
Volume
800,00
52-wk high
CAD 0,46
52-wk low
CAD 0,04
EPS
-CAD 0,02
No. of employees
4
Open
CAD 0,25
High
CAD 0,25
Low
CAD 0,25
Mkt. cap
151,41 m
Avg. vol.
398,90 k
Volume
800,00
52-wk high
CAD 0,46
52-wk low
CAD 0,04
EPS
-CAD 0,02
No. of employees
4
News stories
From web sources and news partners
About BetterLife Pharma Inc
CEO-
Employees4
Founded2002
HeadquartersVancouver, Brits-Columbië, Kanada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Okt. 2025
Jan. 2026
Apr. 2026
Jul. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11,98 k
58,50 k
21,50 k
66,62 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
377,24 k
378,51 k
539,89 k
1,11 m
Operating expense
389,22 k
437,01 k
561,40 k
1,18 m
Total operating expenses
389,22 k
437,01 k
561,40 k
1,18 m
Operating income
-389,22 k
-437,01 k
-561,40 k
-1,18 m
Other non operating income
49,60 k
21,21 k
-27,03 k
-758,12 k
EBT including unusual items
-420,13 k
-381,62 k
-612,62 k
-2,09 m
EBT excluding unusual items
-420,13 k
-391,57 k
-641,94 k
-2,09 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-409,01 k
-380,55 k
-609,26 k
-2,08 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-35,76 k
-71,50 k
-29,80 k
-66,31 k
Net interest expenses
-35,76 k
-71,50 k
-29,80 k
-66,31 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme